Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

50
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
50
Coagulation01:09

Coagulation

7.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

52
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
52
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

41
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
41
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

959
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
959

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robotic-Assisted Laparoscopic Repair of Petit's Hernia With Preperitoneal Mesh.

Cureus·2024
Same author

Babesiosis Presenting as Splenic Rupture in the Midwest: A Case Report.

Cureus·2024
Same author

Stage II Medullary Carcinoma of the Colon: A Surgery Case Report.

Cureus·2024
Same author

Acute Large Bowel Obstruction Caused by Endometriosis Requiring Sigmoidectomy.

Cureus·2023
Same author

On Patterns of Neuropsychiatric Symptoms in Patients With COVID-19: A Systematic Review of Case Reports.

Cureus·2022
Same author

Mantle Cell Lymphoma With Non-traumatic Splenic Rupture Requiring Emergency Splenectomy.

Cureus·2022

Related Experiment Video

Updated: Sep 29, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

898

COVID-19-Induced Hypercoagulability: A Case Report.

Bailey Sperry1, Jenee Joseph2, Benjamin Yglesias3

  • 1Psychiatry, American University of Antigua, College of Medicine, New York, USA.

Cureus
|March 21, 2022
PubMed
Summary

Atherothrombotic microembolism, a rare COVID-19 complication, led to severe lower extremity complications. Despite anticoagulation, limb amputations were necessary, highlighting the critical vascular risks of coronavirus disease 2019.

Keywords:
atherothromboticcase reportcovid-19dichypercoagulabilitymicro-embolism

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.1K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

22.1K

Related Experiment Videos

Last Updated: Sep 29, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

898
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.1K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

22.1K

Area of Science:

  • Vascular Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) has been associated with various thrombotic complications.
  • Atherothrombotic microembolism is a less common but severe vascular event.
  • Understanding COVID-19's impact on microvasculature is crucial for patient management.

Observation:

  • A 53-year-old male with COVID-19 presented with lower extremity mottling 9 days post-diagnosis.
  • Clinical presentation included COVID-19 pneumonia and signs of peripheral ischemia.
  • Lower extremity angiography revealed patent tibial and peroneal arteries despite distal microvascular occlusion.

Findings:

  • The patient developed progressive lower extremity ischemia despite anticoagulation therapy.
  • Multiple surgical amputations, including toe, transmetatarsal, and below-the-knee, were necessitated by the condition.
  • The case illustrates a severe manifestation of atherothrombotic microembolism in the context of COVID-19.

Implications:

  • This case underscores the potential for severe atherothrombotic complications in COVID-19 patients.
  • Aggressive anticoagulation may not always prevent devastating vascular outcomes in severe COVID-19.
  • Further research into COVID-19-associated microvascular thrombosis is warranted to improve treatment strategies.